HWAM
Hennion & Walsh Asset Management’s ADC Therapeutics ADCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-70,636
| Closed | -$317K | – | 839 |
|
|
2024
Q1 | $317K | Buy |
70,636
+4,700
| +7% | +$21.1K | 0.02% | 677 |
|
|
2023
Q4 | $109K | Buy |
65,936
+8,069
| +14% | +$13.4K | 0.01% | 809 |
|
|
2023
Q3 | $51.9K | Buy |
57,867
+2,298
| +4% | +$2.06K | ﹤0.01% | 796 |
|
|
2023
Q2 | $119K | Sell |
55,569
-1,497
| -3% | -$3.21K | 0.01% | 780 |
|
|
2023
Q1 | $111K | Sell |
57,066
-1,803
| -3% | -$3.51K | 0.01% | 756 |
|
|
2022
Q4 | $226K | Buy |
58,869
+7,337
| +14% | +$28.2K | 0.01% | 707 |
|
|
2022
Q3 | $248K | Buy |
51,532
+12,832
| +33% | +$61.8K | 0.02% | 664 |
|
|
2022
Q2 | $308K | Buy |
+38,700
| New | +$308K | 0.02% | 621 |
|